Bibliografia McLaughlin, P. J. and Wu, Y., 1998. Opioid gene expression in the developing and adult rat heart. Dev Dyn. 211, 153-163. McLaughlin, P. J., Wylie, J. D., Bloom, G., Griffith, J. W. and Zagon, I. S., 2002. Chronic exposure to the opioid growth factor, [Met5]-enkephalin, during pregnancy: maternal and preweaning effects. Pharmacol Biochem Behav. 71, 171-181. McMullen, J. R., Shioi, T., Huang, W. Y., Zhang, L., Tarnavski, O., Bisping, E., Schinke, M., Kong, S., Sherwood, M. C., Brown, J., Riggi, L., Kang, P. M. and Izumo, S., 2004. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway. J Biol Chem. 279, 4782-4793. Mendez, M., Cruz, C., Joseph-Bravo, P., Wilk, S. and Charli, J. L., 1990. Evaluation of the role of prolyl endopeptidase and pyroglutamyl peptidase I in the m<strong>eta</strong>bolism of LHRH and TRH in brain. Neuropeptides. 17, 55-62. Mentlein, R., von Kolszynski, M., Sprang, R. and Lucius, R., 1990. Proline-specific proteases in cultivated neuronal and glial cells. Brain Res. 527, 159-162. Mesiano, S., Young, I. R., Hey, A. W., Browne, C. A. and Thorburn, G. D., 1989. Hypophysectomy of the f<strong>eta</strong>l lamb leads to a fall in the plasma concentration of insulin-like growth factor I (IGF-I), but not IGF-II. Endocrinology. 124, 1485- 1491. Miale, I. L. and Sidman, R. L., 1961. An autoradiographic analysis of histogenesis in the mouse cerebellum. Exp Neurol. 4, 277-296. Milner, A. D., 1995. Cerebral correlates of visual awareness. Neuropsychologia. 33, 1117-1130. Mineyama, R. and Saito, K., 1998. Partial purification and some properties of pyroglutamyl peptidase from Enterococcus faecalis. Microbios. 94, 47-62. Miyamoto, M., Hirai, K., Heya, T. and Nagaoka, A., 1994. Effects of a sustained release formulation of thyrotropin-releasing hormone on behavioral abnormalities in senescence-accelerated mice. Eur J Pharmacol. 271, 357-366. Moats-Staats, B. M., Price, W. A., Xu, L., Jarvis, H. W. and Stiles, A. D., 1995. Regulation of the insulin-like growth factor system during normal rat lung development. Am J Respir Cell Mol Biol. 12, 56-64. Moessinger, A. C., Harding, R., Adamson, T. M., Singh, M. and Kiu, G. T., 1990. Role of lung fluid volume in growth and maturation of the f<strong>eta</strong>l sheep lung. J Clin Invest. 86, 1270-1277. Moore, T. L., Killiany, R. J., Herndon, J. G., Rosene, D. L. and Moss, M. B., 2003. Impairment in abstraction and set shifting in aged rhesus monkeys. Neurobiol Aging. 24, 125-134. Morain, P., Lestage, P., De Nanteuil, G., Jochemsen, R., Robin, J. L., Guez, D. and Boyer, P. A., 2002. S 17092: a prolyl endopeptidase inhibitor as a potential therapeutic drug for memory impairment. Preclinical and clinical studies. CNS Drug Rev. 8, 31-52. Moreno, B., Rodriguez-Manzaneque, J. C., Perez-Castillo, A. and Santos, A., 1997. Thyroid hormone controls the expression of insulin-like growth factor I receptor gene at different levels in lung and heart of developing and adult rats. Endocrinology. 138, 1194-1203. Mori, M., Jayaraman, A., Prasad, C., Pegues, J. and Wilber, J. F., 1982. Distribution of histidyl-proline diketopiperazine [cyclo (His-Pro)] and thyrotropin-releasing Bibliografia 237
Bibliografia hormone (TRH) in the primate central nervous system. Brain Res. 245, 183- 186. Moriyama, A., Nakanishi, M. and Sasaki, M., 1988. Porcine muscle prolyl endopeptidase and its endogenous substrates. J Biochem (Tokyo). 104, 112- 117. Morley, J. E., 1979. Extrahypothalamic thyrotropin releasing hormone (TRH) -- its distribution and its functions. Life Sci. 25, 1539-1550. Morley, J. E., 1981. Neuroendocrine control of thyrotropin secretion. Endocr Rev. 2, 396-436. Morrison, J. H. and Hof, P. R., 2002. Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease. Prog Brain Res. 136, 467-486. Moss, M. B., Killiany, R. J., Lai, Z. C., Rosene, D. L. and Herndon, J. G., 1997. Recognition memory span in rhesus monkeys of advanced age. Neurobiol Aging. 18, 13-19. Mugica, J., 1987. Influencia de la edad avanzada en la actividad aminopeptidásica del cerebro de la rata. In: Lizentziatura Tesina; Zientzi<strong>eta</strong>ko Fakultatea). UPV/EHU, Leioa. Muglia, L., Jacobson, L., Dikkes, P. and Majzoub, J. A., 1995. Corticotropin-releasing hormone deficiency reveals major f<strong>eta</strong>l but not adult glucocorticoid need. Nature. 373, 427-432. Murphy, E. H. and Magness, R., 1984. Development of the rabbit visual cortex: a quantitative Golgi analysis. Exp Brain Res. 53, 304-314. Myren, J., Bang, S., Linnestad, P., Stave, R., Hanssen, L. E., Dolva, L. O., Serck- Hanssen, A., Arnesen, K., Stromme, J., Beraki, K. and et al., 1989. Liver cell necrosis and regeneration following injections of carbon tetrachloride. Effects of the thyrotropin-releasing hormone and somatostatin. Apmis. 97, 334-342. Nakano, M. and Tauchi, H., 1988. Age-related alteration of renal brush border leucine aminopeptidase in rat kidney cortex. Mech Ageing Dev. 45, 51-58. Neff, N. T., Prevette, D., Houenou, L. J., Lewis, M. E., Glicksman, M. A., Yin, Q. W. and Oppenheim, R. W., 1993. Insulin-like growth factors: putative musclederived trophic agents that promote motoneuron survival. J Neurobiol. 24, 1578-1588. Neiberger, R. E., 1992. Developmental changes in the renal capacity for sulfate reabsorption in the guinea pig. Pediatr Nephrol. 6, 65-67. Ng, T. B. and Ng, S. L., 1990. B<strong>eta</strong>-endorphin-like and adrenocorticotropin-like materials in heart tissues of the rat, gerbil, hamster and guinea pig. Comp Biochem Physiol C. 95, 45-53. Nguyen, L., Rigo, J. M., Rocher, V., Belachew, S., Malgrange, B., Rogister, B., Leprince, P. and Moonen, G., 2001. Neurotransmitters as early signals for central nervous system development. Cell Tissue Res. 305, 187-202. Nieuwenhuys, R., 1974. Topological analysis of the brain stem: a general introduction. J Comp Neurol. 156, 255-276. Nillni, E. A. and Sevarino, K. A., 1999. The biology of pro-thyrotropin-releasing hormone-derived peptides. Endocr Rev. 20, 599-648. Ninomiya, Y., Koyama, Y. and Kayama, Y., 2001. Postnatal development of choline acetyltransferase activity in the rat laterodorsal tegmental nucleus. Neurosci Lett. 308, 138-140. 238 Bibliografia
- Page 1 and 2:
Jakintza-arloa: Medikuntza Prolil e
- Page 3 and 4:
UNIVERSIDAD DEL PAIS VASCO Eman ta
- Page 5 and 6:
Doktore-tesia Naiara Agirregoitia M
- Page 7 and 8:
Esker onak Lan hau hasi nuenetik mo
- Page 9:
David Artola Blancoren Oroimenez Es
- Page 12 and 13:
Aurkibidea SARRERA 1.NEUROPEPTIDOAK
- Page 14 and 15:
Aurkibidea 7.4. BIRIKAK 65 7.5. GIL
- Page 16:
Aurkibidea 2.4.PIROGLUTAMIL PEPTIDA
- Page 19 and 20:
Sarrera 2 Sarrera
- Page 21 and 22:
Neuropeptidoak dira: 4 Hurrengo tau
- Page 23 and 24:
Neuropeptidoak 6 1.2.4. Askapena Ne
- Page 26 and 27:
Tirotropinaren Hormona Askatzailea
- Page 28 and 29:
Tirotropinaren Hormona Askatzailea
- Page 30 and 31:
Tirotropinaren Hormona Askatzailea
- Page 32 and 33:
Tirotropinaren Hormona Askatzailea
- Page 34:
Tirotropinaren Hormona Askatzailea
- Page 37 and 38:
Prolil endopeptidasa burututako leh
- Page 39 and 40:
Prolil endopeptidasa 22 3.3. PROLIL
- Page 41 and 42:
Prolil endopeptidasa 24 3.5. GARRAN
- Page 43 and 44:
Piroglutamil peptidasa I Mutagenesi
- Page 45 and 46:
Piroglutamil peptidasa I Katuaren g
- Page 48 and 49:
5. GARUN GARAPENA 5.1. SARRERA 5.1.
- Page 50 and 51:
Garun garapena Rhombentzefaloaren k
- Page 52 and 53:
Garun garapena mekanismoa hurrengoe
- Page 54 and 55:
Garun garapena Oinarrizko morfologi
- Page 56 and 57:
Garun garapena egunetan, baina 40.
- Page 58 and 59:
Garun garapena badaude, eta entzima
- Page 60 and 61:
Garun garapena neuronen genesia (Fr
- Page 62 and 63:
Garun garapena hipotiroideoaren adi
- Page 64 and 65:
Garun garapena azpiko zati bat. Bi
- Page 66 and 67:
Garun garapena lank., 1984; Gayo et
- Page 68 and 69:
Organo periferikoen garapena 6.ORGA
- Page 70 and 71:
Organo periferikoen garapena Peptid
- Page 72 and 73:
Organo periferikoen garapena eta la
- Page 74 and 75:
Organo periferikoen garapena Birike
- Page 76:
Organo periferikoen garapena ondore
- Page 79 and 80:
Zahartzapena Entzefalinak eta TRH-a
- Page 81 and 82:
Zahartzapena Bradikininaren hartzai
- Page 83 and 84:
Zahartzapena igoerarekin bat dator.
- Page 86 and 87:
HELBURUA
- Page 88 and 89:
HELBURUA Helburua Organismoaren haz
- Page 90 and 91:
Helburua Peptidasa solugarrien egin
- Page 92 and 93:
MATERIALAK ETA METODOAK
- Page 94 and 95:
MATERIALAK ETA METODOAK Materialak
- Page 96 and 97:
3. PRODUKTU KIMIKOAK o Azetato sodi
- Page 98 and 99:
Materialak 4.2.ENTSEIU ENTZIMATIKOE
- Page 100 and 101:
B. METODOAK 1. ANIMALIEN PERFUSIO E
- Page 102 and 103:
1. IRUDIA: Animaliaren perfusioa. M
- Page 104 and 105:
3. IRUDIA: Garunaren lehenengo ebak
- Page 106 and 107:
2. LAGINEN PRESTAKUNTZA Metodoak Au
- Page 108 and 109:
Metodoak 3.AKTIBITATE ENTZIMATIKOAR
- Page 110 and 111:
Teknika Metodoak Substratu soluzioa
- Page 112 and 113:
Metodoak Materialak eta Metodoak 95
- Page 114 and 115:
EMAITZAK Prolil endopeptidasa solug
- Page 116:
UP/mg proteina 3000 2000 1000 0 Pro
- Page 119 and 120:
Mintzari loturiko prolil endopeptid
- Page 122 and 123:
1.2. PIROGLUTAMIL PEPTIDASA I 1.2.1
- Page 124:
UP/mg proteina 5000 4000 3000 2000
- Page 127 and 128:
Mintzari loturiko piroglutamil pept
- Page 129 and 130:
Prolil endopeptidasa garapenean 112
- Page 131 and 132:
Prolil endopeptidasa garapenean ham
- Page 133 and 134:
Prolil endopeptidasa garapenean PRO
- Page 135 and 136:
Prolil endopeptidasa garapenean Kor
- Page 137 and 138:
Prolil endopeptidasa solugarria gar
- Page 139 and 140:
Prolil endopeptidasa solugarria gar
- Page 141 and 142:
Prolil endopeptidasa solugarria gar
- Page 143 and 144:
Mintzari loturiko prolil endopeptid
- Page 146 and 147:
Mintzari loturiko prolil endopeptid
- Page 148 and 149:
Mintzari loturiko prolil endopeptid
- Page 150 and 151:
Mintzari loturiko prolil endopeptid
- Page 152 and 153:
UP/mg proteina 3000 2000 1000 0 Min
- Page 154 and 155:
UP/mg proteina 500 400 300 200 100
- Page 156 and 157:
UP/mg proteina 300 200 100 0 Mintza
- Page 158 and 159:
Piroglutamil peptidasa I solugarria
- Page 160 and 161:
Piroglutamil peptidasa I solugarria
- Page 162 and 163:
Piroglutamil peptidasa I solugarria
- Page 164 and 165:
Piroglutamil peptidasa I solugarria
- Page 166 and 167:
Piroglutamil peptidasa I solugarria
- Page 168 and 169:
Piroglutamil peptidasa I solugarria
- Page 170 and 171:
Mintzari loturiko piroglutamil pept
- Page 172 and 173:
Mintzari loturiko piroglutamil pept
- Page 174 and 175:
UP/mg proteina 600 400 200 0 Mintza
- Page 176 and 177:
UP/mg proteina 400 300 200 100 0 Mi
- Page 178 and 179:
UP/mg proteina 400 300 200 100 0 Mi
- Page 180 and 181:
UP/mg proteina 200 150 100 50 0 Min
- Page 182 and 183:
UP/mg proteina 150 100 50 0 Mintzar
- Page 184 and 185:
Prolil endopeptidasa zahartzapenean
- Page 186 and 187:
Prolil endopeptidasa zahartzapenean
- Page 188 and 189:
Prolil endopeptidasa zahartzapenean
- Page 190 and 191:
Prolil endopeptidasa zahartzapenean
- Page 192 and 193:
Prolil endopeptidasa zahartzapenean
- Page 194 and 195:
Piroglutamil peptidasa I solugarria
- Page 196 and 197:
UP/ mg proteina 400 300 200 100 0 P
- Page 198:
UP/ mg proteina 5000 4000 3000 2000
- Page 201 and 202: Piroglutamil peptidasa I solugarria
- Page 203 and 204: Piroglutamil peptidasa I solugarria
- Page 205 and 206: EZTABAIDA
- Page 207 and 208: EZTABAIDA 1. PROLIL ENDOPEPTIDASA P
- Page 209 and 210: Prolil endopeptidasa Jaio berrian e
- Page 211 and 212: Prolil endopeptidasa peptido hauek
- Page 213: Prolil endopeptidasa 1.4. PROLIL EN
- Page 216 and 217: Piroglutamil peptidasa I Lehen aipa
- Page 218 and 219: Piroglutamil peptidasa I TRH-aren e
- Page 221 and 222: Emaitzen Analisi orokorra 3. EMAITZ
- Page 223 and 224: ONDORIOAK
- Page 225 and 226: ONDORIOAK Ondorioak 1. Prolil endop
- Page 228: BIBLIOGRAFIA
- Page 231 and 232: Bibliografia Aoyagi, T., Hatsu, M.,
- Page 233 and 234: Bibliografia Berl, S. and Clarke, D
- Page 235 and 236: Bibliografia Carr, F. E., Need, L.
- Page 237 and 238: Bibliografia de Gandarias, J. M., C
- Page 239 and 240: Bibliografia el-Dahr, S. S., 1997.
- Page 241 and 242: Bibliografia Gil, J., 1997. Ontogen
- Page 243 and 244: Bibliografia importance of cardiac
- Page 245 and 246: Bibliografia converting enzyme inhi
- Page 247 and 248: Bibliografia Lee, H. J., Sagawa, K.
- Page 249: Bibliografia Manaker, S., Eichen, A
- Page 253 and 254: Bibliografia Otto, C., Zuschratter,
- Page 255 and 256: Bibliografia Re, R. N., 2003a. Impl
- Page 257 and 258: Bibliografia Sidman, R. L., 1961. H
- Page 259 and 260: Bibliografia ten Have-Opbroek, A. A
- Page 261 and 262: Bibliografia Weil-Malherbe, H., 197
- Page 263: Bibliografia Zagon, I. S., Verderam